Rapid antigen test not needed after recovering from COVID-19 infection

Dr. Yong Poovorawan, head of the Centre of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, says that there is no need for a person who has…

Read More

New weapons – and precautions – as controls lifted on COVID ‘magic bullets’

From Thursday (September 1), COVID-19 patients can buy prescription antiviral medicines from pharmacies, as authorities ease access to weapons against the virus. “Health agencies are offering easier access to these…

Read More

COVID patients caught in crossfire of battle over drug monopoly

Although COVID-19 patients have the option of being treated at private hospitals, health authorities still insist that doctors only prescribe antiviral drugs according to Medical Services Department (MDS) guidelines. Other…

Read More

Klang Hospital’s wards full of COVID-19 patients, anti-viral drugs still being provided

The 8-bed ICU for severe COVID-19 cases requiring ventilators and the 30-bed cohort ward at the Bangkok Metropolitan Administration (BMA)’s General Hospital, also known as Klang Hospital, is now fully…

Read More
Photo Courtesy of Zendai

Elderly COVID patient dies at home as hospital refuses to send ambulance

An 82-year-old bed-ridden patient has died at home, about a week after she was found to be infected with COVID-19. She did not develop any typical symptoms and a hospital…

Read More
Image Credit: Government Pharmaceutical Organisation

Health Ministry seeks additional 75 million anti-viral pills ahead of Songkran

The Ministry of Public Health has asked the Government Pharmaceutical Organization (GPO) for an additional 75 million Favipiravir and Molnupiravir anti-viral medicines, as it anticipates a surge in COVID-19 infections…

Read More

Two million capsules of Molnupiravir received by Thai Medical Services

The Thai Department of Medical Services took delivery of two million capsules, or 50,000 courses, of Molnupiravir anti-viral medicine today (Friday) from Merck and Ridgeback Biotherapeutics, the joint developers and…

Read More
“AFP PHOTO /Merck & Co,Inc./HANDOUT”

Thailand signs ฿500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication

Thailand’s Medical Services Department signed a 500-million baht deal with MSD (Thailand) today (Thursday) to buy 50,000 courses of Merck’s Molnupiravir (Lagevrio) oral anti-viral medication for the treatment of COVID-19…

Read More

Purchase of Molnupiravir COVID-19 drug approved

Thailand’s cabinet on Tuesday approved the planned purchase of Merck’s Mulnupiravir COVID-19 anti-viral drug, with a budget of 500 million Baht set for 50,000 courses of the drug, amounting to…

Read More
Photo from AP

Thailand not eligible to produce generic Molnupiravir anti-viral drug

Thailand is not eligible to produce a generic version of Merck’s Molnupiravir anti-viral drug, which is shown to reduce hospitalisations and deaths among COVID-19 patients by 50%, because it is…

Read More

COVID-19 pill may revive old, bitter debate

Common sense, whether it’s humanitarian or economic, dictates that if the world has found a drug that can make the coronavirus a lot less scary, the treatment should be made…

Read More

CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug

Thailand’s Centre for COVID-19 Situation Administration (CCSA) today (Thursday) approved the Public Health Ministry’s proposal to procure 50,000 courses of the anti-viral Molnupiravir drug, made by US pharmaceutical company Merck. …

Read More

Thailand to import 200,000 courses of Molnupiravir anti-viral drug from USA

The Ministry of Public Health is to seek approval from the Thai cabinet for the procurement of 200,000 courses of the Molnupiravir oral anti-viral medicine, using money from the Central…

Read More

Page 1 of 1


Welcome! Login in to your account

Remember me Lost your password?

Lost Password